SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-144146
Filing Date
2023-05-15
Accepted
2023-05-15 07:10:30
Documents
14
Period of Report
2023-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d481241d8k.htm   iXBRL 8-K 25418
2 EX-99.1 d481241dex991.htm EX-99.1 53009
6 GRAPHIC g481241img001.jpg GRAPHIC 7672
  Complete submission text file 0001193125-23-144146.txt   224459

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iron-20230515.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iron-20230515_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iron-20230515_pre.xml EX-101.PRE 11718
8 EXTRACTED XBRL INSTANCE DOCUMENT d481241d8k_htm.xml XML 3466
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39438 | Film No.: 23918357
SIC: 2834 Pharmaceutical Preparations